Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV
暂无分享,去创建一个
M. Lederman | D. Moisi | J. Currier | J. Stein | D. Anthony | S. Deeks | H. Ribaudo | B. Rodriguez | P. Hsue | L. Calabrese | M. Freeman | B. Clagett | Eunice Yeh | C. D. Morris | Angela Y. Ryu
[1] R. Siliciano,et al. Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo , 2020, bioRxiv.
[2] M. Lederman,et al. CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosis , 2020, PLoS pathogens.
[3] M. Lederman,et al. "Inflammescent" CX3CR1+CD57+ CD8 T cells are generated and expanded by IL-15. , 2020, JCI insight.
[4] T. Aune,et al. Methotrexate and its mechanisms of action in inflammatory arthritis , 2020, Nature Reviews Rheumatology.
[5] C. Kovacs,et al. BCL-2 antagonism sensitizes cytotoxic t cell-resistant hiv reservoirs to elimination ex vivo. , 2020, The Journal of clinical investigation.
[6] P. Palma,et al. Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART , 2019, Viruses.
[7] P. Libby,et al. Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events , 2019, The New England journal of medicine.
[8] M. Lederman,et al. CD8+ T-Cell-Derived Tumor Necrosis Factor Can Induce Tissue Factor Expression on Monocytes. , 2019, The Journal of infectious diseases.
[9] M. Lederman,et al. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] P. Ridker,et al. Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate: AIDS Clinical Trials Group Study A5314 , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[11] Shengyun Liu,et al. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis , 2018, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[12] J. Asara,et al. The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels. , 2017, Cell reports.
[13] Daniel I. S. Rosenbloom,et al. Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics , 2017, The Journal of experimental medicine.
[14] M. Lederman,et al. IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. , 2016, The Journal of clinical investigation.
[15] J. Kremer,et al. Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures , 2016, RMD Open.
[16] M. Osiri,et al. Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics , 2016, Clinical Rheumatology.
[17] M. Lederman,et al. SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Krüppel-like Factor 2 and Endothelial Dysfunction. , 2016, The Journal of infectious diseases.
[18] D. O'Brien,et al. Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size , 2016, Journal of Virology.
[19] L. Hancox,et al. Inflammatory IL-15 is required for optimal memory T cell responses. , 2015, The Journal of clinical investigation.
[20] Stephen Brown,et al. Methotrexate Is a JAK/STAT Pathway Inhibitor , 2015, PloS one.
[21] M. Lederman,et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. , 2014, The Journal of infectious diseases.
[22] M. Lederman,et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. , 2014, The Journal of infectious diseases.
[23] M. Lederman,et al. Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease. , 2014, The Journal of infectious diseases.
[24] P. Tugwell,et al. Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis , 2014, The Journal of Rheumatology.
[25] S. Deeks,et al. Immunologic basis of cardiovascular disease in HIV-infected adults. , 2012, The Journal of infectious diseases.
[26] J. Aviña-Zubieta,et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies , 2012, Annals of the rheumatic diseases.
[27] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[28] D. Greenwood,et al. Meta-analysis of Observational Studies , 2012 .
[29] J. Olesen,et al. Extended Report , 2022 .
[30] B. Cronstein,et al. Methotrexate—how does it really work? , 2010, Nature Reviews Rheumatology.
[31] S. Prey,et al. Effect of folic or folinic acid supplementation on methotrexate‐associated safety and efficacy in inflammatory disease: a systematic review , 2009, The British journal of dermatology.
[32] P. van Riel,et al. Methotrexate modulates the kinetics of adenosine in humans in vivo , 2005, Annals of the rheumatic diseases.
[33] B. Ludviksson,et al. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. , 2005, Clinical immunology.
[34] G. Alarcón,et al. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[35] F. Breedveld,et al. Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis , 2004, Annals of the rheumatic diseases.
[36] J. Marvel,et al. Control of proliferation by Bcl-2 family members. , 2004, Biochimica et biophysica acta.
[37] A. Gerards,et al. UvA-DARE ( Digital Academic Repository ) Inhibition of cytokine production by methotrexate . Studies in healthy volunteers and patients with rheumatoid arthritis , 2007 .
[38] B. Dijkmans,et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. , 2001, Arthritis and rheumatism.
[39] Andreas Radbruch,et al. Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor α, increase of interleukin 10, and predicted by the initial concentration of interleukin 4 , 2000 .
[40] P. Tugwell,et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. , 2000, The Cochrane database of systematic reviews.
[41] L. Genestier,et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. , 1998, The Journal of clinical investigation.
[42] J. Esdaile,et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. , 1993, Arthritis and rheumatism.
[43] M. Weinblatt,et al. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. , 1993, The Journal of rheumatology.
[44] I. Böhm,et al. Mechanism of Action of Methotrexate: Experimental Evidence that Methotrexate Blocks the Binding of Interleukin 1β to the Interleukin 1 Receptor on Target Cells , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[45] D. M. Hoffman,et al. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. , 1991, Annals of the rheumatic diseases.